|
시장보고서
상품코드
1605903
혈당 모니터링 기기 시장 : 시장 규모, 점유율, 동향, 산업 분석 보고서-제품별, 최종 용도별, 지역별-시장 예측(2025-2034년)Blood Glucose Monitoring Device Market Size, Share, Trends, Industry Analysis Report: By Product, End Use, and Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) - Market Forecast, 2025-2034 |
||||||
Polaris Market Research의 최근 조사에 따르면 혈당 모니터링 기기 시장 규모는 2034년까지 313억 1,000만 달러에 이를 것으로 예상됩니다. 이 조사 보고서는 현재의 시장 역학을 자세히 파악하여 미래 시장 성장에 관한 분석을 제공합니다.
혈당 모니터링 기기 시장은 당뇨병 환자에게 중요한 혈당를 측정 및 관리하기 위해 설계된 기술을 포함하고 있습니다. 건강하지 못한 라이프스타일, 인구의 고령화, 유전적 요인에 의해 당뇨병의 세계 유병률이 상승하고 있기 때문에 효과적인 혈당 관리 솔루션에 대한 수요가 크게 증가하고 있습니다. 혈당 모니터링의 중요성에 대한 인식이 계속 높아지는 가운데 환자와 헬스케어 공급자 모두 당뇨병 관리를 강화하기 위해 이러한 기술을 발전시키고 있습니다.
기술의 진보는 혈당 모니터링 기기 시장의 성장에 중요한 역할을 담당하고 있습니다. 비침습적인 포도당 모니터링, 센서 정확도 향상, 최신 기기의 강화된 연결 기능 등의 기술 혁신은 혈당 모니터링을 보다 효율적이고 사용자 친화적으로 만듭니다. 이러한 진보는 더 나은 질환 관리와 환자 전환 개선에 기여하고 수요 증가를 촉진하고 있습니다.
예를 들어, 2023년 7월, Dexcom, Inc.는 캐나다 보건부의 인증을 받은 차세대 Dexcom G7 Continuous Glucose Monitoring System을 출시했습니다. 이 시스템은 2세 이상의 당뇨병 환자를 위해 설계되어 있습니다.
웨어러블 기기와 스마트 포도당 모니터의 채용이 증가하고 있으며, 실시간 추적과 원활한 데이터 통합이 성장의 원동력이 되고 있습니다. 신흥 시장에서의 헬스케어 지출 증가와 맞물려 재택 검사로의 전환이 이 동향을 더욱 뒷받침하고 있습니다. 사용자 친화적이고 정확하며 저렴한 솔루션을 우선으로 전략적 파트너십 및 세계 시장 확대를 도모하는 기업은 이 성장 동향을 활용하는 데 유리한 위치에 있습니다.
혈당 모니터링 기기 시장 보고서 하이라이트
제품별로는 자가 혈당 측정 기기 분야가 2024년 시장을 독점했습니다. 이는 주로 소비자 의식의 고조, 재택 검사의 편리성, 당뇨병 유병률의 상승에 의한 것입니다.
병원 및 클리닉 부문은 당뇨병 환자 수 증가, 입원 환자 수 증가, 기술 진보, 더 나은 환자 관리를 위한 지속적인 포도당 모니터링의 중요성이 높아짐에 따라 가장 빠른 CAGR을 나타낼 것으로 예상됩니다.
북미는 미국과 캐나다와 같은 국가에서 당뇨병 유병률이 높고 고도의 헬스케어 인프라와 같은 요인으로 인해 2024년 시장을 독점했습니다.
아시아태평양은 도시화의 진전과 라이프 스타일의 변화가 당뇨병 이환율 상승에 기여하는 중국과 인도 등 국가에서 당뇨병 이환율 상승으로 가장 빠른 CAGR을 나타낼 것으로 예상됩니다.
주요 시장 기업은 Abbott Laboratories; Acon Laboratories Inc.; ARKRAY Inc.; Bayer AG; Becton, Dexcom, Inc.; F. Hoffmann-La Roche Ltd.; Medtronic Plc; Johnson & Johnson; Novo Nordisk A/S; Sanofi; Terumo Corporation; Ypsomed. 등이 있습니다.
목차
제1장 서론
제2장 주요 요약
제3장 조사 방법
제4장 세계의 혈당 모니터링 기기 시장 인사이트
- 시장 현황
- 혈당 모니터링 기기 시장 역학
- 성장 촉진요인 및 기회
- 고도의 혈당 모니터링 기기 증가
- 고령화 인구 증가
- 억제요인 및 과제
- 대체품의 가용성과 고비용
- 성장 촉진요인 및 기회
- PESTEL 분석
- 혈당 모니터링 기기 시장 동향
- 밸류체인 분석
- COVID-19의 영향 분석
제5장 세계의 혈당 모니터링 기기 시장 : 제품별
- 주요 조사 결과
- 서문
- 자기 감시 장치
- 지속 혈당 측정 장치
제6장 세계의 혈당 모니터링 기기 시장 : 최종 용도별
- 주요 조사 결과
- 서문
- 병원 및 클리닉
- 진단센터
- 가정치료 환경
제7장 세계의 혈당 모니터링 기기 시장 : 지역별
- 주요 조사 결과
- 서문
- 혈당 모니터링 기기 시장 평가 : 지역별(2020-2034년)
- 북미
- 북미 : 제품별(2020-2034년)
- 북미 : 최종 용도별(2020-2034년)
- 미국
- 캐나다
- 유럽
- 유럽 : 제품별(2020-2034년)
- 유럽 : 최종 용도별(2020-2034년)
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
- 아시아태평양
- 아시아태평양 : 제품별(2020-2034년)
- 아시아태평양 : 최종 용도별(2020-2034년)
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
- 중동 및 아프리카
- 중동 및 아프리카 : 제품별(2020-2034년)
- 중동 및 아프리카 : 최종 용도별(2020-2034년)
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 남아프리카
- 기타 중동 및 아프리카
- 라틴아메리카
- 라틴아메리카 : 제품별(2020-2034년)
- 라틴아메리카 : 최종 용도별(2020-2034년)
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카
제8장 경쟁 구도
- 확대 및 인수 분석
- 확대
- 인수
- 제휴, 협업, 합의 및 공개
제9장 기업 프로파일
- Abbott Laboratories
- Acon Laboratories, Inc.
- ARKRAY Inc.
- Bayer AG
- BD
- Dexcom, Inc.
- F. Hoffmann-La Roche Ltd.
- Johnson & Johnson
- Medtronic Plc
- Novo Nordisk A/S
- Sanofi
- Terumo Corporation
- Ypsomed
The blood glucose monitoring devices market size is expected to reach USD 31.31 billion by 2034, according to a new study by Polaris Market Research. The report "Blood Glucose Monitoring Devices Market Size, Share, Trends, Industry Analysis Report: By Product, End-Use, and Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) - Market Forecast, 2025-2034." gives a detailed insight into current market dynamics and provides analysis on future market growth.
The blood glucose monitoring devices market encompasses technologies designed to measure and manage blood glucose levels, which are crucial for diabetic patients. The rising global prevalence of diabetes, driven by unhealthy lifestyles, aging populations, and genetic factors, has significantly increased the demand for effective glucose management solutions. As awareness of the importance of monitoring blood glucose levels continues to grow, both patients and healthcare providers are advancing these technologies to enhance diabetes care.
Technological advancements are playing a crucial role in the growth of the blood glucose monitoring devices market. Innovations such as non-invasive glucose monitoring, improved sensor accuracy, and enhanced connectivity features in modern devices are making blood glucose monitoring more efficient and user-friendly. These advancements contribute to better disease management and improved patient outcomes, driving increased demand.
For instance, in July 2023, Dexcom, Inc. launched the next-generation Dexcom G7 Continuous Glucose Monitoring System, certified by Health Canada. This system is designed for individuals with diabetes aged two years and older.
The increasing adoption of wearable devices and smart glucose monitors is driving growth in real-time tracking and seamless data integration. The shift toward home-based testing, coupled with rising healthcare spending in emerging markets, further supports this trend. Companies that prioritize user-friendly, accurate, and affordable solutions, along with strategic partnerships and global market expansion, are well-positioned to capitalize on this growing trend.
Blood Glucose Monitoring Devices Market Report Highlights
By product outlook, the self-monitoring devices segment dominated the market in 2024, mainly due to increasing consumer awareness, the convenience of home testing, and the rising prevalence of diabetes.
The hospitals & clinics segment is expected to register the fastest CAGR due to the growing number of diabetic patients, increasing hospital admissions, advancements in technology, and a rising emphasis on continuous glucose monitoring for better patient management.
North America dominated the market in 2024 due to factors such as the high prevalence of diabetes and advanced healthcare infrastructure in countries like the United States and Canada.
Asia Pacific is expected to register the fastest CAGR, owing to the rising prevalence of diabetes in countries such as China and India, where increasing urbanization and lifestyle changes contribute to higher diabetes rates.
The key market players include Abbott Laboratories; Acon Laboratories Inc.; ARKRAY Inc.; Bayer AG; Becton, Dexcom, Inc.; F. Hoffmann-La Roche Ltd.; Medtronic Plc; Johnson & Johnson; Novo Nordisk A/S; Sanofi; Terumo Corporation; Ypsomed.
Polaris Market Research has segmented the blood glucose monitoring devices market report based on product, end-use, and region:
By Product Outlook (Revenue - USD Billion, 2020-2034)
- Self-monitoring Devices
- Blood Glucose Meter
- Testing Strips
- Lancets
- Continuous Blood Glucose Monitoring Devices
- Sensors
- Transmitter & Receiver
- Insulin Pumps
By End-Use Outlook (Revenue-USD Billion, 2020-2034)
- Hospitals & Clinics
- Diagnostic Centers
- Home Care Settings
By Regional Outlook (Revenue-USD Billion, 2020-2034)
- North America
- US
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Australia
- Vietnam
- Rest of Asia Pacific
- Latin America
- Argentina
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
- Rest of the Middle East & Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Blood Glucose Monitoring Device Market Insights
- 4.1. Blood Glucose Monitoring Device Market - Market Snapshot
- 4.2. Blood Glucose Monitoring Device Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rise in Advanced Blood Glucose Monitoring Devices
- 4.2.1.2. Increasing Aging Population
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Availability of substitutes and high cost
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Blood Glucose Monitoring Device Market Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Blood Glucose Monitoring Device Market, by Product
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
- 5.3. Self-Monitoring Devices
- 5.3.1. Global Blood Glucose Monitoring Device Market, by Self-Monitoring Devices, by Region, 2020-2034 (USD Billion)
- 5.3.2. Blood Glucose Meter
- 5.3.2.1. Global Blood Glucose Monitoring Device Market, by Blood Glucose Meter, by Region, 2020-2034 (USD Billion)
- 5.3.3. Testing Strips
- 5.3.3.1. Global Blood Glucose Monitoring Device Market, by Testing Strips, by Region, 2020-2034 (USD Billion)
- 5.3.4. Lancets
- 5.3.5. Global Blood Glucose Monitoring Device Market, by Lancets, by Region, 2020-2034 (USD Billion)
- 5.4. Continuous Blood Glucose Monitoring Devices
- 5.4.1. Global Blood Glucose Monitoring Device Market, by Continuous Blood Glucose Monitoring Devices, by Region, 2020-2034 (USD Billion)
- 5.4.2. Sensors
- 5.4.3. Global Blood Glucose Monitoring Device Market, by Sensors, by Region, 2020-2034 (USD Billion)
- 5.4.4. Transmitter & Receiver
- 5.4.5. Global Blood Glucose Monitoring Device Market, by Transmitter & Receiver, by Region, 2020-2034 (USD Billion)
- 5.4.6. Insulin Pumps
- 5.4.7. Global Blood Glucose Monitoring Device Market, by Insulin Pumps, by Region, 2020-2034 (USD Billion)
6. Global Blood Glucose Monitoring Device Market, by End Use
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
- 6.3. Hospitals & Clinics
- 6.3.1. Global Blood Glucose Monitoring Device Market, by Hospitals & Clinics, by Region, 2020-2034 (USD Billion)
- 6.4. Diagnostic Centers
- 6.4.1. Global Blood Glucose Monitoring Device Market, by Diagnostic Centers, by Region, 2020-2034 (USD Billion)
- 6.5. Home Care Settings
- 6.5.1. Global Blood Glucose Monitoring Device Market, by Home Care Settings, by Region, 2020-2034 (USD Billion)
7. Global Blood Glucose Monitoring Device Market, by Geography
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Blood Glucose Monitoring Device Market Assessment, By Geography, 2020-2034 (USD Billion)
- 7.3. Blood Glucose Monitoring Device Market - North America
- 7.3.1. North America: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
- 7.3.2. North America: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
- 7.3.3. Blood Glucose Monitoring Device Market - U.S.
- 7.3.3.1. U.S.: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
- 7.3.3.2. U.S.: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
- 7.3.4. Blood Glucose Monitoring Device Market - Canada
- 7.3.4.1. Canada: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
- 7.3.4.2. Canada: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
- 7.4. Blood Glucose Monitoring Device Market - Europe
- 7.4.1. Europe: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
- 7.4.2. Europe: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
- 7.4.3. Blood Glucose Monitoring Device Market - UK
- 7.4.3.1. UK: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
- 7.4.3.2. UK: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
- 7.4.4. Blood Glucose Monitoring Device Market - France
- 7.4.4.1. France: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
- 7.4.4.2. France: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
- 7.4.5. Blood Glucose Monitoring Device Market - Germany
- 7.4.5.1. Germany: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
- 7.4.5.2. Germany: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
- 7.4.6. Blood Glucose Monitoring Device Market - Italy
- 7.4.6.1. Italy: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
- 7.4.6.2. Italy: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
- 7.4.7. Blood Glucose Monitoring Device Market - Spain
- 7.4.7.1. Spain: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
- 7.4.7.2. Spain: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
- 7.4.8. Blood Glucose Monitoring Device Market - Netherlands
- 7.4.8.1. Netherlands: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
- 7.4.8.2. Netherlands: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
- 7.4.9. Blood Glucose Monitoring Device Market - Russia
- 7.4.9.1. Russia: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
- 7.4.9.2. Russia: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
- 7.4.10. Blood Glucose Monitoring Device Market - Rest of Europe
- 7.4.10.1. Rest of Europe: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
- 7.4.10.2. Rest of Europe: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
- 7.5. Blood Glucose Monitoring Device Market - Asia Pacific
- 7.5.1. Asia Pacific: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
- 7.5.2. Asia Pacific: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
- 7.5.3. Blood Glucose Monitoring Device Market - China
- 7.5.3.1. China: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
- 7.5.3.2. China: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
- 7.5.4. Blood Glucose Monitoring Device Market - India
- 7.5.4.1. India: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
- 7.5.4.2. India: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
- 7.5.5. Blood Glucose Monitoring Device Market - Malaysia
- 7.5.5.1. Malaysia: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
- 7.5.5.2. Malaysia: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
- 7.5.6. Blood Glucose Monitoring Device Market - Japan
- 7.5.6.1. Japan: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
- 7.5.6.2. Japan: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
- 7.5.7. Blood Glucose Monitoring Device Market - Indonesia
- 7.5.7.1. Indonesia: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
- 7.5.7.2. Indonesia: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
- 7.5.8. Blood Glucose Monitoring Device Market - South Korea
- 7.5.8.1. South Korea: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
- 7.5.8.2. South Korea: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
- 7.5.9. Blood Glucose Monitoring Device Market - Australia
- 7.5.9.1. Australia: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
- 7.5.9.2. Australia: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
- 7.5.10. Blood Glucose Monitoring Device Market - Rest of Asia Pacific
- 7.5.10.1. Rest of Asia Pacific: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
- 7.5.10.2. Rest of Asia Pacific: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
- 7.6. Blood Glucose Monitoring Device Market - Middle East & Africa
- 7.6.1. Middle East & Africa: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
- 7.6.2. Middle East & Africa: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
- 7.6.3. Blood Glucose Monitoring Device Market - Saudi Arabia
- 7.6.3.1. Saudi Arabia: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
- 7.6.3.2. Saudi Arabia: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
- 7.6.4. Blood Glucose Monitoring Device Market - UAE
- 7.6.4.1. UAE: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
- 7.6.4.2. UAE: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
- 7.6.5. Blood Glucose Monitoring Device Market - Israel
- 7.6.5.1. Israel: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
- 7.6.5.2. Israel: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
- 7.6.6. Blood Glucose Monitoring Device Market - South Africa
- 7.6.6.1. South Africa: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
- 7.6.6.2. South Africa: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
- 7.6.7. Blood Glucose Monitoring Device Market - Rest of Middle East & Africa
- 7.6.7.1. Rest of Middle East & Africa: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
- 7.6.7.2. Rest of Middle East & Africa: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
- 7.7. Blood Glucose Monitoring Device Market - Latin America
- 7.7.1. Latin America: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
- 7.7.2. Latin America: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
- 7.7.3. Blood Glucose Monitoring Device Market - Mexico
- 7.7.3.1. Mexico: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
- 7.7.3.2. Mexico: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
- 7.7.4. Blood Glucose Monitoring Device Market - Brazil
- 7.7.4.1. Brazil: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
- 7.7.4.2. Brazil: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
- 7.7.5. Blood Glucose Monitoring Device Market - Argentina
- 7.7.5.1. Argentina: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
- 7.7.5.2. Argentina: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
- 7.7.6. Blood Glucose Monitoring Device Market - Rest of Latin America
- 7.7.6.1. Rest of Latin America: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
- 7.7.6.2. Rest of Latin America: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
8. Competitive Landscape
- 8.1. Expansion and Acquisition Analysis
- 8.1.1. Expansion
- 8.1.2. Acquisitions
- 8.2. Partnerships/Collaborations/Agreements/Exhibitions
9. Company Profiles
- 9.1. Abbott Laboratories
- 9.1.1. Company Overview
- 9.1.2. Financial Performance
- 9.1.3. Product Benchmarking
- 9.1.4. Recent Development
- 9.2. Acon Laboratories, Inc.
- 9.2.1. Company Overview
- 9.2.2. Financial Performance
- 9.2.3. Product Benchmarking
- 9.2.4. Recent Development
- 9.3. ARKRAY Inc.
- 9.3.1. Company Overview
- 9.3.2. Financial Performance
- 9.3.3. Product Benchmarking
- 9.3.4. Recent Development
- 9.4. Bayer AG
- 9.4.1. Company Overview
- 9.4.2. Financial Performance
- 9.4.3. Product Benchmarking
- 9.4.4. Recent Development
- 9.5. BD
- 9.5.1. Company Overview
- 9.5.2. Financial Performance
- 9.5.3. Product Benchmarking
- 9.5.4. Recent Development
- 9.6. Dexcom, Inc.
- 9.6.1. Company Overview
- 9.6.2. Financial Performance
- 9.6.3. Product Benchmarking
- 9.6.4. Recent Development
- 9.7. F. Hoffmann-La Roche Ltd.
- 9.7.1. Company Overview
- 9.7.2. Financial Performance
- 9.7.3. Product Benchmarking
- 9.7.4. Recent Development
- 9.8. Johnson & Johnson
- 9.8.1. Company Overview
- 9.8.2. Financial Performance
- 9.8.3. Product Benchmarking
- 9.8.4. Recent Development
- 9.9. Medtronic Plc
- 9.9.1. Company Overview
- 9.9.2. Financial Performance
- 9.9.3. Product Benchmarking
- 9.9.4. Recent Development
- 9.10. Novo Nordisk A/S
- 9.10.1. Company Overview
- 9.10.2. Financial Performance
- 9.10.3. Product Benchmarking
- 9.10.4. Recent Development
- 9.11. Sanofi
- 9.11.1. Company Overview
- 9.11.2. Financial Performance
- 9.11.3. Product Benchmarking
- 9.11.4. Recent Development
- 9.12. Terumo Corporation
- 9.12.1. Company Overview
- 9.12.2. Financial Performance
- 9.12.3. Product Benchmarking
- 9.12.4. Recent Development
- 9.13. Ypsomed
- 9.13.1. Company Overview
- 9.13.2. Financial Performance
- 9.13.3. Product Benchmarking
- 9.13.4. Recent Development
